Article information
Full text is only aviable in PDF
REFERENCES
[1]
C García Girón, Y Fernández Pérez, P Salinas Hernández, MA Jara Álvarez.
Cáncer de pulmón II.
Oncología clínica. Patología especial, pp. 57-80
[2]
TC McLoud, PM Bourgouin, RW Greenberg.
Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph-node mapping and sampling.
Radiology, 182 (1992), pp. 319-323
[3]
B Dillemans, G Deneffe, M Verschakelen, M Decramer.
Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer.
Eur J Cardiothorac Surg, 8 (1994), pp. 37-42
[4]
NC Gupta, GM Graeber, HA Bishop.
Comparative efficacy of PET with FDG in evaluation of small (>1 cm), intermediate (1 to 3 cm) and large (>3 cm) lymph node lesions.
Chest, 117 (2000), pp. 773-778
[5]
M Dahlbom, EJ Hoffman, CK Hoh, C Schipers, G Rosenqvist, RA Hawkins, et al.
Whole-body positron emission tomography: part I. Methods and preformance characteristics.
J Nucl Med, 33 (1992), pp. 1191-1199
[6]
RJ Hagge, TZ Wong, RE Coleman.
Positron emission tomography: brain tumors and lung cancer.
Radiol Clin North Am, 39 (2001), pp. 871-881
[8]
J Ortiz Mera, A Pereira Vega, R Ayerbe García, J Gravalos Guzmán, J Maldonado Pérez.
A man with lung cancer and tuberculosis: a false positive by positron emission tomography and its clinical repercussions.
Arch Bronconeumol, 38 (2002), pp. 90-92
[9]
A Alavi, N Gupta, JL Alberini, M Hickeson, LE Adam, P Bhargava, et al.
Positron emission tomography imaging in nonmalignant thoracic disorders.
Semin Nucl Med, 32 (2002), pp. 293-321
[10]
AH Khandani, SM Keller, MD Blaufox.
(18)F-fluorodeoxyglucose positron emission tomography: false-positive lung scan.
Semin Nucl Med, 32 (2002), pp. 212-213
[11]
K Kubota, T Matsuzawa, T Fujiwara, M Ito, J Hatazawa, R Iwata, et al.
Differential diagnosis of lung tumor with positron emission tomography: a prospective study.
J Nucl Med, 31 (1990), pp. 1927-1932
[12]
R Chin Jr, R Ward, JW Keyes, RH Choplin, JC Reed, S Wallenhaupt, et al.
Mediastinal staging of non-small-cell lung cancer with PET.
Am J Respir Crit Care Med, 152 (1995), pp. 2090-2096
[13]
PE Valk, TR Pounds, DM Hopkins, MK Haseman, GA Hofer, HB Greiss, et al.
Staging non-small cell lung cancer by wholebody positron emission tomographic imaging.
Ann Thorac Surg, 60 (1995), pp. 1573-1581
[14]
DA Sazon, SM Santiago, GW Soo Hoo, A Khonsary, C Brown, M Mandelkern, et al.
FDG-PET in the detection and staging of lung cancer.
Am J Respir Crit Care Med, 153 (1996), pp. 417-421
[15]
A Guhlmann, M Storck, J Kotzerke, F Moog, L Sunder-Plasmann, SN Reske.
Lymph node staging in non small cell lung cancer: evaluation by FDG-PET.
Thorax, 52 (1997), pp. 438-441
[16]
JF Vansteenkiste, SG Stroobants, PR de Leyn, PJ Dupont, JA Verschakelen, KL Nackaerts, et al.
Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable nonsmall cell lung cancer: a prospective analysis of 50 cases. Leuven Lung cancer Group.
Chest, 112 (1997), pp. 1480-1486
[17]
JF Vansteenkiste, SG Stroobants, PR De Leyn, PJ Dupont, J Bogaert, A Maes, et al.
Lymph node staging in non small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
J Clin Oncol, 16 (1998), pp. 2142-2149
[18]
CA Saunders, JE Dussek, MJ O'Doherty, MN Maisey.
Evaluation of FDG whole body PET imaging in the staging of lung cancer.
Ann Thorac Surg, 67 (1999), pp. 790-797
[19]
SU Berlangieri, AM Scott, SR Knight, GJ Fitt, OF Hennessy, HJ Tochon-Danguy, et al.
FDG-PET in non-invasive staging of nonsmall cell lung cancer.
Eur Cardiothorac Surg, 16 (1999), pp. 25-30
[20]
EM Marom, HP McAdams, JJ Erasmus, PC Goodman, DK Culhane, RE Coleman, et al.
Staging non-small cell lung cancer with whole body PET.
Radiology, 212 (1999), pp. 803-809
[21]
T Bury, P Rigor.
Contribution of PET for the management of lung cancer.
Rev Pneumol Clin, 56 (2000), pp. 125-131
[22]
MA Farrell, HP McAdams, JE Herndon, EF Patz.
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Radiology, 215 (2000), pp. 886-890
[23]
BA Dwamena, SS Sonnad, JO Angobaldo, RL Wahl.
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s. Meta-analytic comparison of PET and CT.
Radiology, 213 (1999), pp. 530-536
[24]
RM Pieterman, JW Van Putten, JJ Meuzelaar, EL Mooyart, W Vaalburg, GH Koeter, et al.
Preoperative staging of non-small cell lung cancer with positron emission tomography.
N Engl J Med, 343 (2000), pp. 254-261
[25]
A Fritscher-Ravens, KH Bohuslavizki, L Brandt, C Bobrowski, C Lund, WT Knöfel, et al.
Mediastinal lymph node involvement in potentially resectable lung cancer. Comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration.
Chest, 123 (2003), pp. 442-451
[26]
KH Kernstine, KA Mclaughlin, Y Menda, NP Rossi, DJ Kahn, DL Bushnell, et al.
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?.
Ann Thorac Surg, 73 (2002), pp. 394-402
[27]
HJ Jeong, JJ Min, JM Park, JK Chung, BT Kim, JM Jeong, et al.
Determination of the prognostic value of [(18)F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer.
Nucl Med Commun, 23 (2002), pp. 865-870
[28]
LE Heyneman, EF Patz.
PET imaging in patients with bronchioloalveolar cell carcinoma.
Lung Cancer, 38 (2002), pp. 261-266
[29]
T Wang, Y Sun, N Zhou, et al.
Fluorine-18 fluorodeoxyglucose uptake in patients with primary lung cancer.
Zhonghua Wai Ke Za Zhi, 40 (2002), pp. 437-440
[30]
EM Marom, S Sarvis, JE Herndon, EF Patz Jr.
T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.
Radiology, 223 (2002), pp. 453-459
[31]
N Pandit, M Gonen, L Krug, AM Larson.
Prognostic value of [18F] FDG-PET imaging in small cell lung cancer.
Eur J Nucl Med, 30 (2003), pp. 78-84
[32]
JM Pugsley, RA Schmidt, H Vesselle.
The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography.
Cancer J, 8 (2002), pp. 222-233
[33]
WJ Scott, J Shepherd, SS Gambhir.
Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Ann Thorac Surg, 66 (1998), pp. 1876-1885
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
